“Carcinoma de pulmón célula no pequeña: ¿hay diferencias por histología utilizando inmunoterapia?” - page 10

OAK trial: nonsquamous

OAK trial: squamous

Histology

Rittmeyer, A. Lancet 2016

OAK study:

Atezolizumab

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1,2,3,4,5,6,7,8,9 11,12,13,14,15,16,17,18,19,20,...21